SEC Form 4 · accession 0000905148-26-003381
Core Scientific, Inc./tx · CORZ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Todd M Duchene
Officer — See remarks
Period of report
Jul 27, 2026
Accepted (ET)
Jul 29, 2026 · 4:29 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001839341
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Jul 27, 2026 | S | 8,300 | $20.7469 | D | 1,990,801 | D | |
| Common StockF3 | Jul 27, 2026 | S | 1,600 | $21.8925 | D | 1,989,201 | D | |
| Common Stock | Jul 27, 2026 | S | 100 | $22.49 | D | 1,989,101 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 5, 2025.
- F2The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.47 to $21.42, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
- F3The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.47 to $22.44, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
Remarks
Chief Legal and Administrative Officer